Logo Prima Biomed

Welcome to the Newsroom

19 December 2016

Prima BioMed Announces ADR Ratio Change


SYDNEY, AUSTRALIA - Prima BioMed Ltd (ASX: PRR; NASDAQ: PBMD) (“Prima”, the “Company”)
announces a ratio change for the Company's American Depositary Receipt (“ADR”) program. As a
result, the number of the Company's ordinary shares represented by each American Depositary
Share ("ADS") will be changed from thirty (30) ordinary shares to one hundred (100) ordinary
shares. The effective date anticipated for the ratio change is December 28, 2016 (U.S. Eastern
Standard Time).